Total Holdings
155
Portfolio diversification across 155 positions

Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
View ticker symbols, company names, asset types, and allocation percentages for each position
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 | ![]() | Exact Sciences Corporation | Stock | 3.00% |
| 2 | ![]() | Revolution Medicines, Inc | Stock | 2.55% |
| 3 | ![]() | Avidity Biosciences Inc | Stock | 2.49% |
| 4 | ![]() | Insmed Incorporated | Stock | 2.23% |
| 5 | ![]() | Natera, Inc | Stock | 2.17% |
| 6 | ![]() | Regeneron Pharmaceuticals, Inc | Stock | 2.16% |
| 7 | ![]() | Madrigal Pharmaceuticals, Inc | Stock | 2.06% |
| 8 | ![]() | BridgeBio Pharma, Inc | Stock | 1.99% |
| 9 | ![]() | Amgen Inc | Stock | 1.97% |
| 10 | ![]() | United Therapeutics Corporation | Stock | 1.96% |
| 11 | ![]() | Incyte Corporation | Stock | 1.93% |
| 12 | ![]() | Roivant Sciences Ltd | Stock | 1.93% |
| 13 | ![]() | Biogen Inc | Stock | 1.93% |
| 14 | ![]() | Ionis Pharmaceuticals, Inc | Stock | 1.87% |
| 15 | ![]() | Exelixis, Inc | Stock | 1.81% |
| 16 | ![]() | Vertex Pharmaceuticals Incorporated | Stock | 1.77% |
| 17 | ![]() | Gilead Sciences, Inc | Stock | 1.77% |
| 18 | ![]() | AbbVie Inc | Stock | 1.77% |
| 19 | ![]() | Moderna, Inc. | Stock | 1.77% |
| 20 | ![]() | Neurocrine Biosciences, Inc | Stock | 1.61% |
| 21 | ![]() | Halozyme Therapeutics, Inc. | Stock | 1.58% |
| 22 | ![]() | BioMarin Pharmaceutical Inc | Stock | 1.57% |
| 23 | ![]() | PTC Therapeutics, Inc | Stock | 1.57% |
| 24 | ![]() | Vaxcyte, Inc. | Stock | 1.56% |
| 25 | ![]() | Alnylam Pharmaceuticals, Inc | Stock | 1.55% |
| 26 | ![]() | Mirum Pharmaceuticals, Inc. | Stock | 1.55% |
| 27 | ![]() | CRISPR Therapeutics AG | Stock | 1.54% |
| 28 | ![]() | Amicus Therapeutics, Inc. | Stock | 1.53% |
| 29 | A AKRO | Akero Therapeutics, Inc | Stock | 1.48% |
| 30 | ![]() | Alkermes plc | Stock | 1.48% |
| 31 | ![]() | Praxis Precision Medicines, Inc. | Stock | 1.47% |
| 32 | ![]() | Krystal Biotech, Inc | Stock | 1.44% |
| 33 | ![]() | Cidara Therapeutics Inc | Stock | 1.40% |
| 34 | ![]() | Viking Therapeutics Inc | Stock | 1.39% |
| 35 | ![]() | Cytokinetics, Incorporated | Stock | 1.31% |
| 36 | ![]() | TG Therapeutics, Inc | Stock | 1.31% |
| 37 | ![]() | Celcuity Inc. | Stock | 1.29% |
| 38 | ![]() | Protagonist Therapeutics Inc | Stock | 1.28% |
| 39 | ![]() | Rhythm Pharmaceuticals, Inc. | Stock | 1.25% |
| 40 | ![]() | GRAIL, Inc. | Stock | 1.25% |
| 41 | ![]() | ADMA Biologics, Inc | Stock | 1.18% |
| 42 | ![]() | Summit Therapeutics PLC | Stock | 1.13% |
| 43 | ![]() | Scholar Rock Holding Corp | Stock | 1.09% |
| 44 | ![]() | Nuvalent Inc | Stock | 1.05% |
| 45 | ![]() | Ultragenyx Pharmaceutical Inc | Stock | 0.99% |
| 46 | ![]() | ACADIA Pharmaceuticals Inc | Stock | 0.91% |
| 47 | ![]() | Kymera Therapeutics, Inc | Stock | 0.90% |
| 48 | ![]() | Arcellx Inc | Stock | 0.89% |
| 49 | ![]() | Arrowhead Pharmaceuticals, Inc | Stock | 0.88% |
| 50 | ![]() | Dyne Therapeutics Inc | Stock | 0.87% |